BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...

September 28, 2022 | News

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...

September 27, 2022 | News

ClavystBio launches to translate life sciences breakthroughs into health impact

ClavystBio, a company established by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek, today announced its launch to accelerate the commercia...

September 15, 2022 | News

Gilead Sciences Celebrates Top Ranking By Hepatitis and Asian Patient Groups

Gilead also ranks first among peers in Asia by patient groups in this region -- Gilead Sciences, Inc. ranks first among peers for over...

September 15, 2022 | News

Agilent Announces Thought Leader Award to Professor Christoph Herwig

Agilent Technologies Inc. (NYSE: A) announced Christoph Herwig has been selected to receive a prestigious Agilent Thought Leader Awar...

September 14, 2022 | News

Merck strengthens its manufacturing capabilities for single-use assemblies by investing more than € 130 million in Molsheim, France.

Increases manufacturing capacity for the Mobius® single-use portfolio Creates more than 800 jobs by the end of 2028 Investment further strengt...

September 12, 2022 | News

Biocytogen Expands Partnership with Merck

Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...

August 29, 2022 | News

Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies

Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...

August 25, 2022 | News

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...

August 24, 2022 | News

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapi...

August 23, 2022 | News

Merck to Acquire Chemical Business of Mecaro

Acquisition supports “Level Up” growth ambition of Merck’s Electronics business to further expand its regional capabilities and global ...

August 18, 2022 | News

Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions

Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...

August 09, 2022 | News

Biosynth Carbosynth to offer Enzyme Development following Acquisition of EUCODIS Bioscience

Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today that it has signed an agreemen...

August 08, 2022 | News

Thermo Fisher's $76 million investment expands cell culture media production

To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its ...

August 04, 2022 | News

Stay Connected